Vor Biopharma Statistics Share Statistics Vor Biopharma has 124.96M
shares outstanding. The number of shares has increased by 82.69%
in one year.
Shares Outstanding 124.96M Shares Change (YoY) 82.69% Shares Change (QoQ) 0.09% Owned by Institutions (%) 42.64% Shares Floating 64.9M Failed to Deliver (FTD) Shares 557,080 FTD / Avg. Volume 3.03%
Short Selling Information The latest short interest is 14.38M, so 11.51% of the outstanding
shares have been sold short.
Short Interest 14.38M Short % of Shares Out 11.51% Short % of Float 31.6% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.65 and the forward
PE ratio is -4.39.
Vor Biopharma's PEG ratio is
0.23.
PE Ratio -0.65 Forward PE -4.39 PS Ratio 0 Forward PS 59.5 PB Ratio 0.79 P/FCF Ratio -0.76 PEG Ratio 0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vor Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.19,
with a Debt / Equity ratio of 0.33.
Current Ratio 5.19 Quick Ratio 5.19 Debt / Equity 0.33 Debt / EBITDA -0.28 Debt / FCF -0.32 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-735.31K Employee Count 159 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 142.89% in the
last 52 weeks. The beta is 2.06, so Vor Biopharma's
price volatility has been higher than the market average.
Beta 2.06 52-Week Price Change 142.89% 50-Day Moving Average 1.38 200-Day Moving Average 1.02 Relative Strength Index (RSI) 54.43 Average Volume (20 Days) 18,380,932
Income Statement
Revenue n/a Gross Profit n/a Operating Income -121.19M Net Income -116.91M EBITDA -113.39M EBIT -116.91M Earnings Per Share (EPS) -1.7
Full Income Statement Balance Sheet The company has 81.95M in cash and 31.83M in
debt, giving a net cash position of 50.12M.
Cash & Cash Equivalents 81.95M Total Debt 31.83M Net Cash 50.12M Retained Earnings -456.99M Total Assets 109.31M Working Capital 48.12M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -99.66M
and capital expenditures -229K, giving a free cash flow of -99.89M.
Operating Cash Flow -99.66M Capital Expenditures -229K Free Cash Flow -99.89M FCF Per Share -1.45
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
